Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as an injectable powder for intravenous use. It treats severe bacterial infections such as intra‑abdominal infections, pneumonia, meningitis, urinary tract infections and septicemia in hospitalized patients.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used to treat serious bacterial infections in the hospital setting.

- Complicated intra‑abdominal infections: provides bacterial eradication in severe abdominal sepsis. - Complicated urinary tract infections: eliminates resistant uropathogens causing kidney and bladder infection. - Hospital‑acquired pneumonia: targets multidrug‑resistant organisms in ventilated patients. - Meningitis: penetrates the cerebrospinal fluid to treat bacterial meningitis. - Septicemia: rapidly reduces bloodstream bacterial load in systemic infection.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient cranial discomfort. - Rash: erythematous skin eruption. - Elevated liver enzymes: transient hepatic enzyme rise. - Infusion site reactions: redness or pain at IV site.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile colitis: severe diarrhea due to gut flora disruption. - Anaphylaxis: acute hypersensitivity with respiratory or cardiovascular collapse. - Severe hypersensitivity reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal toxicity: acute kidney injury in susceptible individuals. - Neutropenia: marked reduction in neutrophil count.

Careful assessment and monitoring are required when using meropenem.

- Renal function assessment: evaluate creatinine clearance before initiation. - Dose adjustment in renal impairment: modify dosing interval according to renal function. - Monitor for seizures: observe patients with pre‑existing CNS disease. - Use with caution in patients with known hypersensitivity to β‑lactams. - Avoid in individuals with a history of severe carbapenem allergy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Valproic acid: meropenem reduces serum valproate levels, increasing seizure risk. - Cyclosporine: concurrent use may heighten nephrotoxicity. - Aminoglycosides: combined therapy can exacerbate renal impairment.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor electrolytes and renal function. - Warfarin: observe INR for potential anticoagulation changes. - Other antibiotics (e.g., linezolid): assess for antagonistic effects. - Antiepileptic drugs: watch for altered seizure control. - NSAIDs: increased risk of kidney injury, especially in dehydrated patients.